Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galmed Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 11
Partnerships 12
Galmed Pharma Enters into Agreement with University of California 12
Galmed Pharma Enters into Research Agreement with Yeda Research and Development 13
Galmed Pharma Forms Partnership with Icahn School of Medicine at Mount Sinai 14
Licensing Agreements 15
Samil Pharma Enters into Licensing Agreement with Galmed Pharma for Aramchol 15
Equity Offering 16
Galmed Pharma Prices Public Offering of Shares for USD75 Million 16
Galmed Pharma Prices Direct Offering of Shares for USD6 Million 18
Galmed Pharma Raises USD11.6 Million in Public Offering of Shares 19
Galmed Pharma Prices Private Placement of Shares for USD2.4 Million 20
Galmed Pharma Prices Private Placement of Shares for USD0.4 Million 21
Galmed Pharma Raises USD4.8 Million in Public Offering of Shares 22
One Way Liver Genomics to Raise USD0.2 Million in Financing Round 23
Galmed Pharma Completes IPO For US$44 Million 24
Galmed Pharmaceuticals Ltd – Key Competitors 26
Galmed Pharmaceuticals Ltd – Key Employees 27
Galmed Pharmaceuticals Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Nov 05, 2018: Galmed Pharmaceuticals provides business update and reports third quarter 2018 financial results 29
May 09, 2018: Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results 30
Nov 09, 2017: Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update 31
Jul 31, 2017: Galmed Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 32
May 15, 2017: Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results 33
Mar 23, 2017: Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results 34
Corporate Communications 36
Jun 08, 2017: Galmed Pharmaceuticals Announces the Election of Dr. Carol L. Brosgart as a New Member of the Board of Directors 36
Legal and Regulatory 37
Feb 07, 2018: Galmed Granted “Preferred Technological Enterprise” Status Which may Provide the Company With Significant Financial Benefits 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galmed Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Galmed Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 11
Galmed Pharma Enters into Agreement with University of California 12
Galmed Pharma Enters into Research Agreement with Yeda Research and Development 13
Galmed Pharma Forms Partnership with Icahn School of Medicine at Mount Sinai 14
Samil Pharma Enters into Licensing Agreement with Galmed Pharma for Aramchol 15
Galmed Pharma Prices Public Offering of Shares for USD75 Million 16
Galmed Pharma Prices Direct Offering of Shares for USD6 Million 18
Galmed Pharma Raises USD11.6 Million in Public Offering of Shares 19
Galmed Pharma Prices Private Placement of Shares for USD2.4 Million 20
Galmed Pharma Prices Private Placement of Shares for USD0.4 Million 21
Galmed Pharma Raises USD4.8 Million in Public Offering of Shares 22
One Way Liver Genomics to Raise USD0.2 Million in Financing Round 23
Galmed Pharma Completes IPO For US$44 Million 24
Galmed Pharmaceuticals Ltd, Key Competitors 26
Galmed Pharmaceuticals Ltd, Key Employees 27
Galmed Pharmaceuticals Ltd, Subsidiaries 28
List of Figures
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galmed Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galmed Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9